Orange Book product · Generic (ANDA)
DIGOXIN
DIGOXIN
At a glance
Dec 23, 1999
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 23, 1999
26 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
DIGOXIN
Strength
0.125MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 040282
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DIGOXIN
- 2004DIGOXINBrand (NDA)
NDA 021648 · HIKMA
- 1997LANOXINBrand (NDA)
NDA 020405 · ADVANZ PHARMA
- 1982LANOXICAPSBrand (NDA)
NDA 018118 · GLAXOSMITHKLINE LLC
- —LANOXINBrand (NDA)
NDA 009330 · AZURITY
- 2022DIGOXINGeneric (ANDA)
ANDA 215307 · NOVITIUM PHARMA
- 2022DIGOXINGeneric (ANDA)
ANDA 215209 · AMICI PHARMA
- 2022DIGOXINGeneric (ANDA)
ANDA 214982 · AUROBINDO PHARMA LTD
- 2019DIGOXINGeneric (ANDA)
ANDA 213000 · VISTAPHARM LLC
- 2009DIGOXINGeneric (ANDA)
ANDA 078556 · IMPAX LABS
- 2007DIGOXINGeneric (ANDA)
ANDA 077002 · HIKMA INTL PHARMS
- 2003DIGOXINGeneric (ANDA)
ANDA 040481 · SANDOZ
- 2003DIGOXINGeneric (ANDA)
ANDA 076363 · SUN PHARM INDS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
